Written question asked by Andy Slaughter (Labour) on Tuesday, 11 October 2016, in the House of Commons. It was due for an answer on Thursday, 13 October 2016. It was answered by Baroness Blackwood of North Oxford (Conservative) on Wednesday, 19 October 2016 on behalf of the Department of Health.

Muscular Dystrophy: Medical Treatments

Question: To ask the Secretary of State for Health, what new treatments for Duchenne muscular dystrophy have been notified to the Horizon Scanning Research and Intelligence Centre in the last 12 months.

Answer

In the last 12 months, the National Institute for Health Research Horizon Scanning Research and Intelligence Centre has identified and added to its database the following technologies for which Duchenne muscular dystrophy is an indication:

- ezutromid;

- FG-3019;

- follistatin;

- halofuginone hydrobromide;

- SRP-4045;

- SRP-4053; and

- vamorolone.

Secondary information

Type: Written question
Reference: 48137
Session: 2016-17
Subjects: Medical treatments Muscular dystrophy
Link: View this Written question on www.parliament.uk

Muscular Dystrophy: Medical Treatments

Secondary information

Librarians' tools